Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ernberg

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
Cancer Causes & Control : CCC|April 20, 2022
A novel causal model for nasopharyngeal carcinomaE T Chang, W Ye, I Ernberg, et al.
Genome Research|August 3, 2001
Capturing whole-genome characteristics in short sequences using a naïve Bayesian classifierR Sandberg, G Winberg, C I Bränden, et al.
Lakartidningen|August 31, 1988
[Cancer in man caused by virus--an epidemiological overview]I Ernberg, P Biberfeld, E M Fenyö, et al.
Journal of the National Cancer Institute|July 1, 1974
Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. II. Immunoelectron microscopyD Silvestre, I Ernberg, C Neauport-Sautes, et al.
Journal of Immunological Methods|January 1, 1982
Human T cell growth factor (TCGF) produced by repeated stimulation of non-adherent human lymphocytesY Wu, I Ernberg, M G Masucci, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 15, 2000
Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cellsL F Hu, F Chen, E Altiok, et al.
The Journal of General Virology|July 1, 1991
Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNAJ Minarovits, S Minarovits-Kormuta, B Ehlin-Henriksson, et al.
International Journal of Cancer|February 15, 1985
Capacity of B-lymphocytic lines of diverse tumor origin to produce and respond to B-cell growth factors: a progression model for B-cell lymphomagenesisJ Gordon, P Aman, A Rosén, et al.
Journal of Applied Microbiology|February 10, 2009
Inhibition spectrum studies of microthecin and other anhydrofructose derivatives using selected strains of Gram-positive and -negative bacteria, yeasts and moulds, and investigation of the cytotoxicity of microthecin to malignant blood cell linesR Fiskesund, L V Thomas, M Schobert, et al.
Journal of Virology|December 1, 1987
Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell linesJ Finke, M Rowe, B Kallin, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Cancer Causes & Control : CCC|April 20, 2022
A novel causal model for nasopharyngeal carcinomaE T Chang, W Ye, I Ernberg, et al.
Genome Research|August 3, 2001
Capturing whole-genome characteristics in short sequences using a naïve Bayesian classifierR Sandberg, G Winberg, C I Bränden, et al.
Lakartidningen|August 31, 1988
[Cancer in man caused by virus--an epidemiological overview]I Ernberg, P Biberfeld, E M Fenyö, et al.
Journal of the National Cancer Institute|July 1, 1974
Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. II. Immunoelectron microscopyD Silvestre, I Ernberg, C Neauport-Sautes, et al.
Journal of Immunological Methods|January 1, 1982
Human T cell growth factor (TCGF) produced by repeated stimulation of non-adherent human lymphocytesY Wu, I Ernberg, M G Masucci, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 15, 2000
Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cellsL F Hu, F Chen, E Altiok, et al.
The Journal of General Virology|July 1, 1991
Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNAJ Minarovits, S Minarovits-Kormuta, B Ehlin-Henriksson, et al.
International Journal of Cancer|February 15, 1985
Capacity of B-lymphocytic lines of diverse tumor origin to produce and respond to B-cell growth factors: a progression model for B-cell lymphomagenesisJ Gordon, P Aman, A Rosén, et al.
Journal of Applied Microbiology|February 10, 2009
Inhibition spectrum studies of microthecin and other anhydrofructose derivatives using selected strains of Gram-positive and -negative bacteria, yeasts and moulds, and investigation of the cytotoxicity of microthecin to malignant blood cell linesR Fiskesund, L V Thomas, M Schobert, et al.
Journal of Virology|December 1, 1987
Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell linesJ Finke, M Rowe, B Kallin, et al.
Pageof 14